Отдаленные результаты хирургического и комбинированного лечения больных раком верхнеампулярного отдела прямой кишки

Background. Сomparative assessment of long-term oncologic outcomes of surgical and combined treatment of patients with upper rectal cancer.

Materials and methods. Patients aged > 18 with histologycally verified upper T1–4N0–2M0 rectal cancer were included. In group A patients received neoadjuvant chemoradiotherapy 25 Gy in 5 Gy fractions with capecitabine 850 mg/m2 bid per os on radiation days and surgery. In group B patients received surgery alone.

Results. From january 2004 to december 2014, we selected 227 archival cases of patients with upper rectal cancer. Group A was 103 patients (45.4 %) in group B – 123 (54.6 %). We traced long-term results of treatment in 217 (96.6 %) patients. In the group A was 98 (95.1 %) patients, in the group B – 119 (96.7 %) patients. Local recurrence occurred in group A – 1 (1.2 %) patient, in group B – 3 (2.5 %) patients (p = 0.413). The frequency of distant metastases developed in group A in 10 (10.2 %) patients and in group B – 15 (12.6 %) patients (p = 0.581). Overall survival in group A was 90.6 %, and the disease-free survival – 89.6 %, in group B – 82.8 % and 81.9 %, respectively (p = 0.46).

Conclusions. Surgical treatment of patients with upper rectal cancer stage I–III, in compliance with all oncological principles is justified.

1. Glimelius B., Gronberg H., Jarhult J. et al. A systematic overview of radiation therapy effects in rectal cancer. Acta Oncol 2013; 42(5–6):476–92.

2. Статистика злокачественных новообразований в России и странах СНГ в 2012 году. Под ред. М. И. Давыдова, Е. М. Аксель. 2014. [Statistics of malignant tumors in Russia and CIS countries in 2012. Ed. by: М. I. Davydov, Е. М. Аksel’. Мoscow, 2014. 226 p. (In Russ.)].

3. Cecil T.D., Sexton R., Moran B.J., Heald R.J. Total mesorectal excision results in low local recurrence rates in lymph node-positive rectal cancer. Dis Colon Rectum 2004;47:1145–9.

4. Kapiteijn E., Marijnen C. A., Nagtegaal I. D. et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. Engl J Med 2001;345(9): 638–46.

5. Kripp M., Wieneke J., Kienle P. et al. Intensified neoadjuvant chemoradiotherapy in locally advanced rectal cancer – impact on long-term quality of life. Eur J Surg Oncol 2012;38(6):472–7.

6. De Caluwe L., Van Nieuwenhove Y., Ceelen W. P. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer. Cochrane Database Syst Rev 2013;2. CD006041.

7. Folkesson J., Birgisson H., Pahlman L. et al. Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 2005;23(24):5644–50.

8. The Association of Coloproctology of Great Britain and Ireland. Guidelines for the management of colorectal cancer 3rd edition. 2007.

9. Sauer R., Becker H., Hohenberger W. et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351(17):1731–40.

10. Quirke P., Steele R., Monson J. et al. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC–CTG CO16 randomised clinical trial. Lancet 2009;373(9666):821–8.

11. Peeters K. C., Marijnen C. A., Nagtegaal I. D. et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007;246(5):693–701.

12. ESMO Clinical Practice Guidelines. [Электронный ресурс]. 2014. Режим доступа: http://www.esmo.org/content/download/30934/621019/file/ESMO-2014-Industry-Guidelines.

13. Marinello F. G., Frasson M., Baguena G. et al. Selective approach for upper rectal cancer treatment. Hospital Universitarioi Politècnic La Fe Valencia, 2015.

14. Pucciarelli S., Gagliardi G., Maretto I. et al. Long-term oncologic results and complications after preoperative chemoradiotherapy for rectal cancer: a singleinstitution experience after a median followup of 95 months. Ann Surg Oncol 2009;6(4):893–9.

15. Kusters M., Marijnen C. A., van de Velde C. J. et al. Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. Eur J Surg Oncol 2010;36(5): 470–6.